Growth Metrics

Astrana Health (ASTH) Non-Current Deffered Revenue (2016 - 2017)

Astrana Health's Non-Current Deffered Revenue history spans 3 years, with the latest figure at $683504.0 for Q3 2017.

  • For Q3 2017, Non-Current Deffered Revenue fell 16.58% year-over-year to $683504.0; the TTM value through Sep 2017 reached $683504.0, down 16.58%, while the annual FY2017 figure was $747418.0, 2.54% up from the prior year.
  • Non-Current Deffered Revenue for Q3 2017 was $683504.0 at Astrana Health, down from $715462.0 in the prior quarter.
  • Across five years, Non-Current Deffered Revenue topped out at $819375.0 in Q3 2016 and bottomed at $11610.0 in Q1 2015.
  • The 3-year median for Non-Current Deffered Revenue is $728877.0 (2016), against an average of $662599.0.
  • The largest annual shift saw Non-Current Deffered Revenue skyrocketed 6178.01% in 2016 before it decreased 16.58% in 2017.
  • A 3-year view of Non-Current Deffered Revenue shows it stood at $680336.0 in 2015, then increased by 19.7% to $814348.0 in 2016, then fell by 16.07% to $683504.0 in 2017.
  • Per Business Quant, the three most recent readings for ASTH's Non-Current Deffered Revenue are $683504.0 (Q3 2017), $715462.0 (Q2 2017), and $747418.0 (Q1 2017).